New Zealand Legislation: Acts

19 Relevant risks and benefits

• The only risks and benefits relevant to a decision under section 21 are—

  • (a) risks to public health:

  • (ab) risks to trade and market access for primary produce arising from the use of the trade name product:

  • (b) Risks to agricultural security:

  • (c) Risks to the welfare of animals which result from treatment with or exposure to any substance, mixture of substances, or biological compound that forms a part of the trade name product:

  • (d) Risks to domestic food residue standards:

  • (e) The benefits of the trade name product and the likely consequences of the public not having access, or having restricted access, to the trade name product.

  Section 19(a): substituted, on 18 October 2007, by section 14(1) of the Agricultural Compounds and Veterinary Medicines Amendment Act 2007 (2007 No 93).

  Section 19(ab): inserted, on 18 October 2007, by section 14(1) of the Agricultural Compounds and Veterinary Medicines Amendment Act 2007 (2007 No 93).

  Section 19(e): amended, on 18 October 2007, by section 14(2) of the Agricultural Compounds and Veterinary Medicines Amendment Act 2007 (2007 No 93).